104 related articles for article (PubMed ID: 22455980)
1. Neuronal expression of F-box and leucine-rich-repeat protein 2 decreases over Braak stages in the brains of Alzheimer's disease patients.
Watanabe T; von der Kammer H; Wang X; Shintani Y; Horiguchi T
Neurodegener Dis; 2013; 11(1):1-12. PubMed ID: 22455980
[TBL] [Abstract][Full Text] [Related]
2. The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease.
von Rotz RC; Kins S; Hipfel R; von der Kammer H; Nitsch RM
Eur J Neurosci; 2005 Mar; 21(5):1289-98. PubMed ID: 15813938
[TBL] [Abstract][Full Text] [Related]
3. Brain site-specific gene expression analysis in Alzheimer's disease patients.
Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
[TBL] [Abstract][Full Text] [Related]
4. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
5. BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue.
Coulson DT; Beyer N; Quinn JG; Brockbank S; Hellemans J; Irvine GB; Ravid R; Johnston JA
J Alzheimers Dis; 2010; 22(4):1111-22. PubMed ID: 20930286
[TBL] [Abstract][Full Text] [Related]
6. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
[TBL] [Abstract][Full Text] [Related]
7. Zinc transporter mRNA levels in Alzheimer's disease postmortem brain.
Beyer N; Coulson DT; Heggarty S; Ravid R; Hellemans J; Irvine GB; Johnston JA
J Alzheimers Dis; 2012; 29(4):863-73. PubMed ID: 22349685
[TBL] [Abstract][Full Text] [Related]
8. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease.
Barrachina M; Maes T; Buesa C; Ferrer I
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):505-16. PubMed ID: 16972884
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
[TBL] [Abstract][Full Text] [Related]
10. Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease.
Boutillier S; Lannes B; Buée L; Delacourte A; Rouaux C; Mohr M; Bellocq JP; Sellal F; Larmet Y; Boutillier AL; Loeffler JP
Neurodegener Dis; 2007; 4(6):413-23. PubMed ID: 17934324
[TBL] [Abstract][Full Text] [Related]
11. Lib, transcriptionally induced in senile plaque-associated astrocytes, promotes glial migration through extracellular matrix.
Satoh K; Hata M; Shimizu T; Yokota H; Akatsu H; Yamamoto T; Kosaka K; Yamada T
Biochem Biophys Res Commun; 2005 Sep; 335(2):631-6. PubMed ID: 16098915
[TBL] [Abstract][Full Text] [Related]
12. TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.
Culpan D; Cram D; Chalmers K; Cornish A; Palmer L; Palmer J; Hughes A; Passmore P; Craig D; Wilcock GK; Kehoe PG; Love S
Neurobiol Aging; 2009 Jul; 30(7):1052-60. PubMed ID: 18069092
[TBL] [Abstract][Full Text] [Related]
13. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
14. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
15. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
16. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
Papasozomenos SC
Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
[TBL] [Abstract][Full Text] [Related]
17. Decrease of the immunophilin FKBP52 accumulation in human brains of Alzheimer's disease and FTDP-17.
Giustiniani J; Sineus M; Sardin E; Dounane O; Panchal M; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE
J Alzheimers Dis; 2012; 29(2):471-83. PubMed ID: 22233767
[TBL] [Abstract][Full Text] [Related]
18. Distribution of amyloid beta protein precursor in the Alzheimer's disease brain.
Shoji M; Kawarabayashi T; Matsubara E; Ikeda M; Ishiguro K; Harigaya Y; Okamoto K
Psychiatry Clin Neurosci; 2000 Feb; 54(1):45-54. PubMed ID: 15558879
[TBL] [Abstract][Full Text] [Related]
19. Association of estrogen receptor alpha gene polymorphisms with neurofibrillary tangles.
Kazama H; Ruberu NN; Murayama S; Saito Y; Nakahara K; Kanemaru K; Nagura H; Arai T; Sawabe M; Yamanouchi H; Orimo H; Hosoi T
Dement Geriatr Cogn Disord; 2004; 18(2):145-50. PubMed ID: 15211069
[TBL] [Abstract][Full Text] [Related]
20. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
